Gina Consylman

Gina Consylman is an accomplished finance professional with extensive experience in financial leadership roles across various biotech and pharmaceutical companies. Currently serving as the R&D CFO and COO for Takeda since June 2023, Gina also contributes to the Board of Directors and Audit Committee at Assembly Biosciences, Inc. Previous positions include Chief Financial Officer at Vedere Bio II and bluebird bio, as well as SVP and CFO at Ironwood Pharmaceuticals. Gina has held critical roles at Verastem Oncology, Biogen Idec, and Varian Semiconductor, where responsibilities included overseeing accounting teams, managing SEC reporting, and leading corporate governance initiatives. Academic credentials include a Master’s in Taxation from Bentley University and a Bachelor’s in Accounting from Johnson & Wales University.